Dr. Hayes Bordman Gladstone, MD

Dr. Gladstone practices at Gladstone Clinic for Skin Cancer, Lasers, Aesthetic Surgery in Danville, California.

Dr. Gladstone's NPI, 1619003282, was assigned on February 26, 2007. Dr. Gladstone graduated from University of Rochester Medical Center in 1992. Dr. Gladstone holds California license A52367.

Dr. Gladstone's primary practice is Gladstone Clinic for Skin Cancer, Lasers, Aesthetic Surgery, at 3860 Blackhawk Rd, Danville, CA 94506 in Contra Costa County. The practice phone is (925) 837-6000.

Dr. Gladstone's primary practice is Gladstone Clinic for Skin Cancer, Lasers, Aesthetic Surgery in Danville, California. The medical group on file is Gladstone Clinic. Dmand AI also links Dr. Gladstone to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gladstone practices. Vendor and product names are available with a free account.

Dermatology is Dr. Gladstone's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gladstone is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Gladstone's licenses on file in 4 states: California, Hawaii, Oregon and Washington.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Gladstone treats.

CMS data shows 17,956 Medicare services from Dr. Gladstone across 31 procedure codes in 2024, for 424 Medicare patients. Medicare paid $1,950,978 for them. Every service was in an office.

CMS counts 424 Medicare patients who saw Dr. Gladstone in 2024. The largest group is 75 to 84, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gladstone's median patient age at 68, with 55% women.

In 2024, Dr. Gladstone wrote 229 Medicare Part D claims for 114 patients. 97% of them were for generic drugs. CMS names the drug for 129 of them, across 5 drugs with 11 or more claims each, at $949 in total drug cost. In 2023, CMS named 173 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gladstone for performance year 2024, reported individually. Dr. Gladstone accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 59 procedures of melanoma (skin cancer) excision by Dr. Gladstone, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 44 papers to Dr. Gladstone, published from 2006 to 2014. 2012 was the busiest year, with 2. The most frequent topics are Mohs Surgery, Skin Aging and Cosmetic Techniques. Dr. Gladstone has published most often in Dermatol Surg. Dr. Gladstone's most frequent co-authors are Basil M. Hantash, MD, PhD, Daniel Berg, MD and Edgar Franklin Fincher, MD, PhD.

Dmand AI links Dr. Gladstone to 2 clinical trials. Conditions studied include Pilomatrixoma, Urinary Bladder Neoplasms and Neoplasms, Basal Cell. Stanford University sponsors the most, 2.

CMS Open Payments shows 56 general payments to Dr. Gladstone from 22 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 53% of the total. iCAD, Inc paid the most, $3,319.

Dmand AI lists 4 awards for Dr. Gladstone, most recently Regional Top Doctor in 2014.

Dr. Gladstone graduated from University of Rochester Medical Center in 1992. Dr. Gladstone is a member of AAD and ASDS.

Dr. Gladstone is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.